NK cell tolerance and the maternal-fetal interface

American Journal of Reproductive Immunology

Volumn 59, Issue 5, 2008, Pages 371-387

  Riley, Joan K ^a   Yokoyama, Wayne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Licensing; NK cells; Pregnancy; Tolerance; Trophoblast

Indexed keywords

CD94 ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2A;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CELL KILLING; CYTOKINE RELEASE; EFFECTOR CELL; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; TARGET CELL; TROPHOBLAST; UTERUS;

ABORTION, SPONTANEOUS; ANIMALS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY, MATERNAL-FETAL; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY OUTCOME; RECEPTORS, KIR; UTERUS;

EID: 42149101137     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00593.x     Document Type: Review

References (161)

1. Herberman RB: NK Cells and Other Natural Effector Cells. New York, Academic Press, 1982.
2. Yokoyama WM: Natural Killer Cells. New York, Lippincott-Raven, 1999.
3. Bancroft GJ: The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993; 5: 503-510.
4. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP: Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220.
5. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, Blattenberger EA, Dubbelde CE, Stone LR, Scalzo AA, Yokoyama WM: Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001; 292: 934-937.
6. Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM: Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983; 131: 1531-1538.
7. Tripp CS, Wolf SF, Unanue ER: Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A 1993; 90: 3725-3729.
8. Yu YY, Kumar V, Bennett M: Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 1992; 10: 189-213.
9. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F: Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5: 1260-1265.
10. Zitvogel L, Terme M, Borg C, Trinchieri G: Dendritic cell-NK cell cross-talk: Regulation and physiopathology. Curr Top Microbiol Immunol 2006; 298: 157-174.
11. Croy BA, van den Heuvel MJ, Borzychowski AM, Tayade C: Uterine natural killer cells: A specialized differentiation regulated by ovarian hormones. Immunol Rev 2006; 214: 161-185.
12. Moffett-King A: Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2: 656-663.
13. Moffett A, Loke C: Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006; 6: 584-594.
14. Hanna J, Mandelboim O: When killers become helpers. Trends Immunol 2007; 28: 201-206.
15. Peel S: Granulated metrial gland cells. Adv Anat Embryol Cell Biol 1989; 115: 1-112.
16. Kiso Y, McBey BA, Mason L, Croy BA: Histological assessment of the mouse uterus from birth to puberty for the appearance of LGL-1+ natural killer cells. Biol Reprod 1992; 47: 227-232.
17. Croy BA, Kiso Y: GranulateA metrial gland cells: a natural killer cell subset of the pregnant murine uterus. Microsc Res Tech 1993; 25: 189-200.
18. Ashkar AA, Di Santo JP, Croy BA: Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000; 192: 259-270.
19. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O: Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12: 1065-1074.
20. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A: Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200: 957-965.
21. Medawar PB: Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953; 7: 320-338.
22. Trowsdale J, Betz AM: Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 2006; 7: 241-246.
23. Karre K, Ljunggren HG, Piontek G, Kiessling R: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319: 675-678.
24. Ljunggren HG, Karre K: In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237-244.
25. Colonna M, Samaridis J: Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995; 268: 405-408.
26. Karlhofer FM, Ribaudo RK, Yokoyama WM: MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992; 358: 66-70.
27. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995; 2: 439-449.
28. Yokoyama WM: Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc Natl Acad Sci USA 1995; 92: 3081-3085.
29. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795-799.
30. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L: Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996; 14: 619-648.
31. Colonna M: Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev 1997; 155: 127-133.
32. Vivier E, Daeron M: Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997; 18: 286-291.
33. Lanier LL: NK cell receptors. Annu Rev Immunol 1998; 16: 359-393.
34. Long EO: Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999; 17: 875-904.
35. Moretta L, Biassoni R, Bottino C, Mingari MC, Moretta A: Human NK-cell receptors. Immunol Today 2000; 21: 420-422.
36. Raulet DH, Vance RE, McMahon CW: Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001; 19: 291-330.
37. MacFarlane AWT, Campbell KS: Signal transduction in natural killer cells. Curr Top Microbiol Immunol 2006; 298: 23-57.
38. Cerwenka A, Lanier LL: Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1: 41-49.
39. Vilches C, Parham P: KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217-251.
40. Yokoyama WM: Natural killer cell receptors. Curr Opin Immunol 1998; 10: 298-305.
41. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P: Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7: 739-751.
42. Salcedo M, Diehl AD, Olsson-Alheim MY, Sundback J, Van Kaer L, Karre K, Ljunggren HG: Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J Immunol 1997; 158: 3174-3180.
43. Sentman CL, Olsson MY, Karre K: Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration'model for how effector cells adapt to self. Semin Immunol 1995; 7: 109-119.
44. Dorfman JR, Raulet DH: Major histocompatibility complex genes determine natural killer cell tolerance. Eur J Immunol 1996; 26: 151-155.
45. Karlhofer FM, Hunziker R, Reichlin A, Margulies DH, Yokoyama WM: Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J Immunol 1994; 153: 2407-2416.
46. Olsson MY, Karre K, Sentman CL: Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc Natl Acad Sci USA 1995; 92: 1649-1653.
47. Olsson-Alheim MY, Salcedo M, Ljunggren HG, Karre K, Sentman CL: NK cell receptor calibration: Effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells. J Immunol 1997; 159: 3189-3194.
48. Yokoyama WM, Kim S: How do natural killer cells find self to achieve tolerance? Immunity 2006; 24: 249-257.
49. Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D: Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 1991; 349: 329-331.
50. Dorfman JR, Zerrahn J, Coles MC, Raulet DH: The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1-mice. J Immunol 1997; 159: 5219-5225.
51. Furukawa H, Yabe T, Watanabe K, Miyamoto R, Miki A, Akaza T, Tadokoro K, Tohma S, Inoue T, Yamamoto K, Juji T: Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). Hum Immunol 1999; 60: 32-40.
52. Hoglund P, Ohlen C, Carbone E, Franksson L, Ljunggren HG, Latour A, Koller B, Karre K: Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: Nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proc Natl Acad Sci USA 1991; 88: 10332-10336.
53. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D: MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991; 253: 199-202.
54. Ljunggren HG, Van Kaer L, Ploegh HL, Tonegawa S: Altered natural killer cell repertoire in Tap-1 mutant mice. Proc Natl Acad Sci USA 1994; 91: 6520-6524.
55. Vitale M, Zimmer J, Castriconi R, Hanau D, Donato L, Bottino C, Moretta L, de la Salle H, Moretta A: Analysis of natural killer cells in TAP2-deficient patients: Expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood 2002; 99: 1723-1729.
56. Bennett M: Biology and genetics of hybrid resistance. Adv Immunol 1987; 41: 333-445.
57. Cudkowicz G, Stimpfling JH: Hybrid resistance to parental marrow grafts: association with the K region of H-2. Science 1964; 144: 1339-1340.
58. Bennett M, Yu YY, Stoneman E, Rembecki RM, Mathew PA, Lindahl KF, Kumar V: Hybrid resistance: 'negative'and 'positive'signaling of murine natural killer cells. Semin Immunol 1995; 7: 121-127.
59. Ohlen C, Kling G, Hoglund P, Hansson M, Scangos G, Bieberich C, Jay G, Karre K: Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 1989; 246: 666-668.
60. Trowsdale J: Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001; 15: 363-374.
61. Yokoyama WM, Plougastel BF: Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003; 3: 304-316.
62. Makrigiannis AP, Pau AT, Schwartzberg PL, McVicar DW, Beck TW, Anderson SK: A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics 2002; 79: 437-444.
63. Arase H, Arase N, Saito T: Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J Exp Med 1996; 183: 2391-2396.
64. Colucci F, Caligiuri MA, Di Santo JP: What does it take to make a natural killer? Nat Rev Immunol 2003; 3: 413-425.
65. Hackett J Jr, Tutt M, Lipscomb M, Bennett M, Koo G, Kumar V: Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells. J Immunol 1986; 136: 3124-3131.
66. Kim S, Iizuka K, Kang HS, Dokun A, French AR, Greco S, Yokoyama WM: In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002; 3: 523-528.
67. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM: Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005; 436: 709-713.
68. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH: A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005; 105: 4416-4423.
69. Yu YY, Netuschil N, Lybarger L, Connolly JM, Hansen TH: Cutting edge: single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J Immunol 2002; 168: 3145-3149.
70. Dorfman JR, Raulet DH: Acquisition of Ly49 receptor expression by developing natural killer cells. J Exp Med 1998; 187: 609-618.
71. Wu MF, Raulet DH: Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J Immunol 1997; 158: 1628-1633.
72. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D: Granulated lymphocytes in human endometrium: Histochemical and immunohistochemical studies. Hum Reprod (Oxford, England) 1991; 6: 791-798.
73. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633-640.
74. Ferry BL, Starkey PM, Sargent IL, Watt GM, Jackson M, Redman CW: Cell populations in the human early pregnancy decidua: Natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes. Immunology 1990; 70: 446-452.
75. Hanna J, Bechtel P, Zhai Y, Youssef F, McLachlan K, Mandelboim O: Novel insights on human NK cells'immunological modalities revealed by gene expression profiling. J Immunol 2004; 173: 6547-6563.
76. Ritson A, Bulmer JN: Isolation and functional studies of granulated lymphocytes in first trimester human decidua. Clin Exp Immunol 1989; 77: 263-268.
77. Manaseki S, Searle RF: Natural killer (NK) cell activity of first trimester human decidua. Cell Immunol 1989; 121: 166-173.
78. King A, Birkby C, Loke YW: Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol 1989; 118: 337-344.
79. Ashkar AA, Croy BA: Interferon-gamma contributes to the normalcy of murine pregnancy. Biol Reprod 1999; 61: 493-502.
80. Greenwood JD, Minhas K, di Santo JP, Makita M, Kiso Y, Croy BA: Ultrastructural studies of implantation sites from mice deficient in uterine natural killer cells. Placenta 2000; 21: 693-702.
81. Guimond MJ, Luross JA, Wang B, Terhorst C, Danial S, Croy BA: Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice. Biol Reprod 1997; 56: 169-179.
82. Guimond MJ, Wang B, Croy BA: Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med 1998; 187: 217-223.
83. Croy BA, Ashkar AA, Foster RA, DiSanto JP, Magram J, Carson D, Gendler SJ, Grusby MJ, Wagner N, Muller W, Guimond MJ: Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy. J Reprod Immunol 1997; 35: 111-133.
84. Miyazaki S, Tanebe K, Sakai M, Michimata T, Tsuda H, Fujimura M, Nakamura M, Kiso Y, Saito S: Interleukin 2 receptor gamma chain (gamma(c)) knockout mice show less regularity in estrous cycle but achieve normal pregnancy without fetal compromise. Am J Reprod Immunol 2002; 47: 222-230.
85. Ashkar AA, Black GP, Wei Q, He H, Liang L, Head JR, Croy BA: Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J Immunol 2003; 171: 2937-2944.
86. Ashkar AA, Croy BA: Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy. Semin Immunol 2001; 13: 235-241.
87. Clark DE, Smith SK, Licence D, Evans AL, Charnock-Jones DS: Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol 1998; 159: 459-467.
88. Wang C, Umesaki N, Nakamura H, Tanaka T, Nakatani K, Sakaguchi I, Ogita S, Kaneda K: Expression of vascular endothelial growth factor by granulated metrial gland cells in pregnant murine uteri. Cell Tissue Res 2000; 300: 285-293.
89. Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, Licence D, Bowen JM, Gardner L, King A, Loke YW, Smith SK: Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 2001; 86: 1823-1834.
90. Lash GE, Schiessl B, Kirkley M, Innes BA, Cooper A, Searle RF, Robson SC, Bulmer JN: Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol 2006; 80: 572-580.
91. Tayade C, Hilchie D, He H, Fang Y, Moons L, Carmeliet P, Foster RA, Croy BA: Genetic deletion of placenta growth factor in mice alters uterine NK cells. J Immunol 2007; 178: 4267-4275.
92. Wang H, Dey SK: Roadmap toCembryo implantation: clues from mouse models. Nature Rev 2006; 7: 185-199.
93. Loke YW, King A: Human Implantation: Cell Biology and Immunology. Cambridge, Cambridge University Press, 1995.
94. King A, Burrows TD, Hiby SE, Bowen JM, Joseph S, Verma S, Lim PB, Gardner L, Le Bouteiller P, Ziegler A, Uchanska-Ziegler B, Loke YW: Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 2000; 21: 376-387.
95. Ishitani A, Sageshima N, Hatake K: The involvement of HLA-E and -F in pregnancy. J Reprod Immunol 2006; 69: 101-113.
96. Le Bouteiller P, Rodriguez AM, Mallet V, Girr M, Guillaudeux T, Lenfant F: Placental expression of HLA class I genes. Am J Reprod Immunol 1996; 35: 216-225.
97. King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM: HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000; 30: 1623-1631.
98. Schmidt CM, Orr HT: MatTrnal/fetal interactions: the role of the MHC class I molecule HLA-G. Crit Rev Immunol 1993; 13: 207-224.
99. Adamson SL, Lu Y, Whiteley KJ, Holmyard D, Hemberger M, Pfarrer C, Cross JC: Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 2002; 250: 358-373.
100. Cross JC: How to mMke a placenta: mechanisms of trophoblast cell differentiation in mice-a review. Placenta 2005; 26 (Suppl. A): S3-9.
101. Jaffe L, Robertson EJ, Bikoff EK: Distinct patterns of expression of MHC class I and beta 2-microglobulin transcripts at early stages of mouse development. J Immunol 1991; 147: 2740-2749.
102. Jaffe L, Jeannotte L, Bikoff EK, Robertson EJ: Analysis of beta 2-microglobulin gene expression in the developing mouse embryo and placenta. J Immunol 1990; 145: 3474-3482.
103. Redline RW, Lu CY: Localization of fetal major histocompatibility complex antigens and maternal leukocytes in murine placenta. Implications for maternal-fetal immunological relationship. Lab Invest 1989; 61: 27-36.
104. Zuckermann FA, Head JR: Expression of MHC antigens on murine trophoblast and their modulation by interferon. J Immunol 1986; 137: 846-853.
105. Erlebacher A, Lukens AK, Glimcher LH: Intrinsic susceptibility of mouse trophoblasts to natural killer cell-mediated attack in vivo. Proc Natl Acad Sci USA 2002; 99: 16940-16945.
106. Khakoo SI, Aarrington M: KIR and disease: a model system or system of models? Immunol Rev 2006; 214: 186-201.
107. Zimmer J, Donato L, Hanau D, Cazenave JP, Tongio MM, Moretta A, de la Salle H: Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med 1998; 187: 117-122.
108. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagne F, Ugolini S, Vivier E: Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006; 25: 331-342.
109. Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC: Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 2007; 179: 5977-5989.
110. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A: Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100.
111. Chantakru S, Miller C, Roach LE, Kuziel WA, Maeda N, Wang WC, Evans SS, Croy BA: Contributions from self-renewal and trafficking to the uterine NK cell population of early pregnancy. J Immunol 2002; 168: 22-28.
112. Kusumi M, Yamashita T, Fujii T, Nagamatsu T, Kozuma S, Taketani Y: Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells. J Reprod Immunol 2006; 70: 33-42.
113. Ponte M, Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC: Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 1999; 96: 5674-5679.
114. Vacca P, Pietra G, Falco M, Romeo E, Bottino C, Bellora F, Prefumo F, Fulcheri E, Venturini PL, Costa M, Moretta A, Moretta L, Mingari MC: Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood 2006; 108: 4078-4085.
115. Jacobs R, Hintzen G, Kemper A, Beul K, Kempf S, Behrens G, Sykora KW, Schmidt RE: CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol 2001; 31: 3121-3127.
116. Keskin DB, Allan DS, Rybalov B, Andzelm MM, Stern JN, Kopcow HD, Koopman LA, Strominger JL: TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells. Proc Natl Acad Sci USA 2007; 104: 3378-3383.
117. Lynch L, Golden-Mason L, Eogan M, O'Herlihy C, O'Farrelly C: Cells with haematopoietic stem cell phenotype in adult human endometrium: Relevance to infertility? Hum Reprod (Oxford, England) 2007; 22: 919-926.
118. Hiby SE, King A, Sharkey AM, Loke YW: Human uterine NK cells have a similar repertoire of killer inhibitory and activatory receptors to those found in blood, as demonstrated by RT-PCR and sequencing. Mol Immunol 1997; 34: 419-430.
119. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL: Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198: 1201-1212.
120. Kopcow HD, Allan DS, Chen X, Rybalov B, Andzelm MM, Ge B, Strominger JL: Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA 2005; 102: 15563-15568.
121. Verma S, King A, Loke YW: Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur J Immunol 1997; 27: 979-983.
122. Chrul S, Polakowska E, Szadkowska A, Bodalski J: Influence of interleukin IL-2 and IL-12+ IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells. Mediators Inflamm 2006; 2006: 46957.
123. Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS: KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 2003; 171: 3415-3425.
124. Hill JA: Cytokines in Early Pregancy Success and Failure. New York, Wiley-Liss, Inc., 2000.
125. Jawerbaum A, GonTalez E: Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Current Med Chem 2006; 13: 2127-2138.
126. Laird SM, Tuckerman EM, Li TC: Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13: 13-23.
127. Tomassetti C, Meuleman C, Pexsters A, Mihalyi A, Kyama C, Simsa P, D'Hooghe TM: Endometriosis, recurrent miscarriage and implantation failure: Is there an immunological link? Reprod Biomed Online 2006; 13: 58-64.
128. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL: Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000; 12: 721-727.
129. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH: Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000; 1: 119-126.
130. Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, Vivier E, Raulet DH: Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 2002; 3: 1142-1149.
131. Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M: NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol 2002; 3: 1150-1155.
132. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T: Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2: 255-260.
133. Ho EL, Carayannopoulos LN, Poursine-Laurent J, Kinder J, Plougastel B, Smith HR, Yokoyama WM: Costimulation of multiple NK cell activation receptors by NKG2D. J Immunol 2002; 169: 3667-3675.
134. Mistry AR, O'Callaghan CA: Regulation of ligands for the activating receptor NKG2D. Immunology 2007; 121: 439-447.
135. Diefenbach A, Raulet DH: Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 2003; 15: 37-44.
136. Xie X, He H, Colonna M, Seya T, Takai T, Croy BA: Pathways participating in activation of mouse uterine natural killer cells during pregnancy. Biol Reprod 2005; 73: 510-518.
137. Martin MP, Carrington M: Immunogenetics of viral infections. Curr Opin Immunol 2005; 17: 510-516.
138. Varla-Leftherioti M: Role of a KIR/HLA-C allorecognition system in pregnancy. J Reprod Immunol 2004; 62: 19-27.
139. Redman CWP Current topic: pre-eclampsia and the placenta. Placenta 1991; 12: 301-308.
140. Pijnenborg R, Vercruysse L, Hanssens M: The uterine spiral arteries in human pregnancy: Facts and controversies. Placenta 2006; 27: 939-958.
141. Moffett A, Hiby SE: How does the maternal immune system contribute to the development of pre-eclampsia? Placenta 2007; 28 (Suppl. A): S51-56.
142. Redman CW: Immunology of preeclampsia. Semin Perinatol 1991; 15: 257-262.
143. Walker JJ: Pre-eclampsia. Lancet 2000; 356: 1260-1265.
144. Colonna M, Brooks EG, Falco M, Ferrara GB, Strominger JL: Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 1993; 260: 1121-1124.
145. Mandelboim O, Reyburn HT, Vales-Gomez M, Pazmany L, Colonna M, Borsellino G, Strominger JL: Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 1996; 184: 913-922.
146. Parham P: MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005; 5: 201-214.
147. Johansson S, Johansson M, Rosmaraki E, Vahlne G, Mehr R, Salmon-Divon M, Lemonnier F, Karre K, Hoglund P: Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med 2005; 201: 1145-1155.
148. Clifford K, Rai R, Watson H, Regan L: An informative protocol for the investigation of recurrent miscarriage: Preliminary experience of 500 consecutive cases. Hum Reprod (Oxford, England) 1994; 9: 1328-1332.
149. Stirrat GM: Recurrent miscarriage. Lancet 1990; 336: 673-675.
150. Clifford K, Flanagan AM, Regan L: Endometrial CD56+ natural killer cells in women with recurrent miscarriage: A histomorphometric study. Hum Reprod (Oxford, England) 1999; 14: 2727-2730.
151. Lachapelle MH, Miron P, Hemmings R, Roy DC: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156: 4027-4034.
152. Quenby S, Bates M, Doig T, Brewster J, Lewis-Jones DI, Johnson PM, Vince G: Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod (Oxford, England) 1999; 14: 2386-2391.
153. Quenby S, Farquharson R: Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13: 24-28.
154. Vassiliadou N, Bulmer JN: Immunohistochemical evidence for increased numbers of 'classic'CD57+ natural killer cells in the endometrium of women suffering spontaneous early pregnancy loss. Hum Reprod (Oxford, England) 1996; 11: 1569-1574.
155. Moffett A, Regan L, Braude P: Natural killer cells, miscarriage, and infertility. BMJ 2004; 329: 1283-1285.
156. Varla-Leftherioti M, Spyropoulou-Vlachou M, Niokou D, Keramitsoglou T, Darlamitsou A, Tsekoura C, Papadimitropoulos M, Lepage V, Balafoutas C, Stavropoulos-Giokas C: Natural killer (NK) cell receptors'repertoire in couples with recurrent spontaneous abortions. Am J Reprod Immunol 2003; 49: 183-191.
157. Varla-Leftherioti M, Spyropoulou-Vlachou M, Keramitsoglou T, Papadimitropoulos M, Tsekoura C, Graphou O, Papadopoulou C, Gerondi M, Stavropoulos-Giokas C: Lack of the appropriate natural killer cell inhibitory receptors in women with spontaneous abortion. Hum Immunol 2005; 66: 65-71.
158. Chao KH, Wu MY, Chen CD, Yang JH, Yang YS, Ho HN: The expression of killer cell inhibitory receptors on natural killer cells and activation status of CD4+ and CD8+ T cells in the decidua of normal and abnormal early pregnancies. Hum Immunol 1999; 60: 791-797.
159. Wang S, Zhao YR, Jiao YL, Wang LC, Li JF, Cui B, Xu CY, Shi YH, Chen ZJ: Increased activating killer immunoglobulin-like receptor genes and decreased specific HLA-C alleles in couples with recurrent spontaneous abortion. Biochem Biophys Res Commun 2007; 360: 696-701.
160. Witt CS, Goodridge J, Gerbase-Delima MG, Daher S, Christiansen FT: Maternal KIR repertoire is not associated with recurrent spontaneous abortion. Hum Reprod (Oxford, England) 2004; 19: 2653-2657.
161. Chewning JH, Gudme CN, Hsu KC, Selvakumar A, Dupont B: KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J Immunol 2007; 179: 854-868.